BIOA CIK: 1709941

BioAge Labs, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
25.3
FY24:
357
FY25:
287
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.62
FY24:
1.13
FY25:
8.10
Total assets
Change from FY23 to FY25
millions USD
FY23:
25.9
FY24:
358
FY25:
295

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
58.2
FY24:
27.8
FY25:
20.1
(negative)
Change from FY23 to FY25
millions USD
FY23:
8.43
FY24:
7.33
FY25:
2.70
(positive)
Change from FY23 to FY25
millions USD
FY23:
−173
FY24:
323
FY25:
272
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
358
FY25:
295

All amounts in millions USD Data source:SEC EDGAR